BioSpace News Archive

Deals

Cerecor to Acquire Aevi Genomic Medicine

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan and rare diseases, as well as neurology announced today it has entered into a definitive merger agreement to acquire Aevi Genomic Medicine

December 5, 2019
·
14 min read
Pharm Country

Beneath the Breast Campaign from Eisai and METAvivor Supports Relationship Challenges Commonly Faced by People Living with Metastatic Breast Cancer and their Loved Ones

Latest Initiative of #ThisIsMBC to be Unveiled at the 2019 San Antonio Breast Cancer Symposium

December 5, 2019
·
5 min read
Pharm Country

Akers Biosciences Continues Strategic Review; Explores Leveraging its 30-years of Laboratory Operations to Enter into the Hemp and Minor Cannabinoid Processing Industry

Establishes Advisory Board appointing Bob Hoban and Michael Patterson

December 5, 2019
·
4 min read
Genetown

SVH Launches its Blockchain-Powered Auditing API, Aletheia, on the Microsoft Azure Store

SVH is excited to announce a crucial tool for driving trust and value: Aletheia, a straightforward event-logging API that increases trust between data-sharing partners.

December 5, 2019
·
2 min read
Business

Spheryx Co-Founder, Prof. David Grier, Named a Fellow of the National Academy of Inventors

Spheryx Co-Founder, Prof. David Grier, professor of physics at New York University, and inventor of Spheryx’s Total Holographic Characterization®, has been elected into the National Academy of Inventors

December 5, 2019
·
2 min read
Shineco, Inc. Regains Compliance with Nasdaq Continued Listing Requirement and Rules with Respect to Annual Meeting of Shareholders

On July 1, 2019, the Company received a written notification from the Nasdaq Listing Qualifications Staff indicating that the Company did not comply with the annual meeting requirement for continued listing on The Nasdaq Capital Market set forth in Listing Rule 5620

December 5, 2019
·
2 min read
Business

Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that Dr. Yaakov Waksman is to join the company as Head of Cannabidiol Research.

December 5, 2019
·
4 min read
Pharm Country

PANTHERx Adds Another Quarter of #1 Patient Satisfaction Results to Impressive History of National Recognitions

For the third quarter of 2019, PANTHERx obtained the highest Net Promoter Score (NPS) among all specialty pharmacies surveyed including retail, hospital/health system, PBM/payer, and independent specialty pharmacies.

December 5, 2019
·
2 min read
Lone Star Bio

US Oncology Research Announces Schedule of Presentations at the 2019 American Society of Hematology Annual Meeting and Exposition

Top researchers will present abstracts on latest clinical research advancing cancer treatment options

December 5, 2019
·
5 min read
Dante Labs Launches Whole GenomeH, the First Human Whole Genome Sequencing Test With Hybrid Genome Assembly

Dante Labs announced its newest, in-house, sequencing test: GenomeH – the first hybrid whole genome sequencing test to leverage hybrid genome assembly and combine short and long reads sequencing in a single application, for superior coverage, accuracy and precision of the genome.

December 5, 2019
·
1 min read